In vitro and In vivo Anticancer Activity of Semisynthetic Derivatives of Betulinic acid

Joseph, Alex and Kutty, Nampurath G and Moorkoth, Sudheer and Alex, Angel Treasa (2019) In vitro and In vivo Anticancer Activity of Semisynthetic Derivatives of Betulinic acid. Latin American Journal of Pharmacy, 38 (8). pp. 1582-1590. ISSN 0326- 2383

[img] PDF
7112 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (835kB) | Request a copy


SUMMARY. A-ring modifications of betulinic acid isolated from Diospyros peregrina was carried out and the chemically moified derivatives were characterized by spectroscopic methods. Chemically modified betulinic acid analogues were subjected to molecular docking studies on topoisomerase-1 and were evaluated for in vitro and in vivo anticancer activity. In vitro anticancer studies revealed that among semisynthetic derivatives of betulinic acid the 2- benzylidene derivatives BE-6 and BE-7 as the most active compounds against HeLa and MDA-MB-435 cell lines. Compounds BE-6 and BE-7 exhibited apoptosis-mediated cell death and caused cell cycle arrest at the G0/G1 phase of HeLa cells. The in vivo Ehrlich ascites carcinoma model further confirms the antitumor efficacy BE-6 and BE-7. Molecular docking studies reveal that introduction of benzylidene group in the second position of betulinic acid has improved the binding affinity to topoisomerase-1. Further, the anticancer property of betulinic acid derivatives was in agreement with molecular docking results.

Item Type: Article
Uncontrolled Keywords: Anticancer; Betulinic acid; Docking; Ehrlich’s ascites; Topoisomerase
Subjects: Pharmacy > MCOPS Manipal > Pharmaceutical Biotechnology
Pharmacy > MCOPS Manipal > Pharmaceutical Chemistry
Pharmacy > MCOPS Manipal > Pharmaceutical Quality Assurance
Pharmacy > MCOPS Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 13 Sep 2019 04:58
Last Modified: 13 Sep 2019 04:58

Actions (login required)

View Item View Item